Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
4
Bearish filings
22
Named actors
8
Disclosed $ (bull / bear)
$0 / $17.5M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-13 | 5%+ holder (13G) — increased stake Janus Henderson Group Ltd. | increased its stake (13D/G amendment) | — | SEC ↗ |
| 2026-06-30 | CEO and President Shefferman Jesse | gifted | — | SEC ↗ |
| 2026-06-30 | CEO and President Shefferman Jesse | gifted | — | SEC ↗ |
| 2026-06-30 | CEO and President Shefferman Jesse | gifted | — | SEC ↗ |
| 2026-06-30 | CEO and President Shefferman Jesse | gifted | — | SEC ↗ |
1 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-06-29 | CEO and President Shefferman Jesse | sold | $882K | SEC ↗ |
| 2026-06-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JESSE SHEFFERMAN | filed notice to sell | $882K | SEC ↗ |
| 2026-05-28 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-04-23 | Former Affiliate (via Jefferies LLC) 667, L.P. | filed notice to sell | $133K | SEC ↗ |
| 2026-04-23 | Former Affiliate (via Jefferies LLC) Baker Brothers Life Sciences, L.P. | filed notice to sell | $1.6M | SEC ↗ |
| 2026-04-08 | Chief R&D Officer Zummo Jacqueline | sold | $6K | SEC ↗ |
| 2026-04-01 | Officer (via THE CHARLES SCHWAB CORPORATION) Zummo Jacqueline | filed notice to sell | $125K | SEC ↗ |
| 2026-03-17 | President, Chief Executive Officer and Director Jesse Shefferman | adopted a selling plan | — | SEC ↗ |
| 2026-03-17 | President, Chief Executive Officer and Director Jesse Shefferman | terminated a selling plan | — | SEC ↗ |
| 2026-03-06 | Former Affiliate (via Canaccord Genuity LLC) Baker Brothers Life Sciences, L.P. | filed notice to sell | $2.7M | SEC ↗ |
| 2026-03-06 | Former Affiliate (via Canaccord Genuity LLC) 667, L.P. | filed notice to sell | $224K | SEC ↗ |
| 2026-03-04 | Former Affiliate (via Canaccord Genuity LLC) Baker Brothers Life Sciences, L.P. | filed notice to sell | $2.7M | SEC ↗ |
| 2026-03-04 | Former Affiliate (via Canaccord Genuity LLC) 667, L.P. | filed notice to sell | $220K | SEC ↗ |
| 2026-03-02 | 5%+ holder (13G) MILLENNIUM MANAGEMENT LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-25 | Former Affiliate (via Canaccord Genuity LLC) Baker Brothers Life Sciences, L.P. | filed notice to sell | $5.5M | SEC ↗ |
| 2026-02-25 | Former Affiliate (via Canaccord Genuity LLC) 667, L.P. | filed notice to sell | $457K | SEC ↗ |
| 2026-02-24 | Former Affiliate (via Canaccord Genuity LLC) Baker Brothers Life Sciences, L.P. | filed notice to sell | $1.9M | SEC ↗ |
| 2026-02-24 | Former Affiliate (via Canaccord Genuity LLC) 667, L.P. | filed notice to sell | $162K | SEC ↗ |
| 2025-12-31 | Chief R&D Officer Jacqueline Zummo | adopted a buying plan | — | SEC ↗ |
| 2025-12-05 | Issuer (share issuance) | priced an offering | — | SEC ↗ |